Anuj Goenka

Clinical trials

• Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM

  Sub-investigator · Recruiting · Phase 1, Phase 2

  Northwell Health

  2017–2029
• Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma

  Sub-investigator · Recruiting · Phase 1, Phase 2

  Northwell Health

  2016–2029
• Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA

  Sub-investigator · Recruiting · Phase 2

  Northwell Health

  2016–2036